recombinant murine gas6  (R&D Systems)

Journal: European journal of immunology

Article Title: TAM receptors attenuate murine NK cell responses via E3 ubiquitin ligase Cbl-b

doi: 10.1002/eji.201948204

Figure Lengend Snippet: LAKs were serum/IL-2-starved for 2 hours, pre-treated with or without Gas6 for 2 hours, and left unstimulated (Unstim) or stimulated with PMA/Iono, anti-NK1.1, or anti-NKG2D for 5 hours and analyzed by flow cytometry using the strategy illustrated in Supporting Information (Figure S1A). (A) Representative flow cytometric plots of IFN-γ+ and CD107a+ LAK cells are shown. (B) The fraction of IFN-γ-expressing and (C) CD107a-expressing LAKs from 4 independent experiments are shown (n = 4 mice for anti-NK1.1 and n=5 mice for anti-NKG2D). (D) Splenoctyes from Poly I:C-treated mice were pre-treated with or without Gas6 for 2 hours and left unstimulated (Unstim) or stimulated with PMA/Iono or anti-NK1.1 for 5 hours and analyzed by flow cytometry using the strategy illustrated in Supporting Information (Figure S1B). Representative flow cytometric plots of IFN-γ+ and CD107a+ NK cells are shown. The fraction of (E) IFN-γ-expressing and (F) CD107a–expressing splenocytes of 4 independent experiments are shown (n =4–5 mice). *p<0.05 and **p<0.01 by paired Student t test, respectively; ns, not significant.

Article Snippet: Recombinant murine Gas6 was purchased from R&D systems (Minneapolis, MN).

Techniques: Flow Cytometry, Expressing

Journal: European journal of immunology

Article Title: TAM receptors attenuate murine NK cell responses via E3 ubiquitin ligase Cbl-b

doi: 10.1002/eji.201948204

Figure Lengend Snippet: (A) LAKs were treated with media (0.05% DMSO) or BMS 777607 (100 nM) for 2 hours in IL-2/serum-free conditions, followed by treatment with or without Gas6 for another 2 hours prior to stimulation with anti-NK1.1 or NKG2D for 5 hours. Data is shown as mean % inhibition {(Untreated - Gas6-treated)/Untreated]*100} ± SEM of 4 independent experiments (n = 4–5 mice for anti-NK1.1 and n=5–6 mice for anti-NKG2D). P values were determined by paired Student t test. (B) WT and Cbl-b KO LAKs were serum/IL-2-starved for 2 hours, followed by Gas6 treatment for 2 hours, and stimulated with anti-NK1.1 or (C) anti-NKG2D antibodies for 24 hours. IFNγ content in the supernatants was measured by ELISA. Data are represented as % of control + SEM of n=4 mice for anti-NK1.1 and n=3 mice for anti-NKG2D. *p< 0.05 and ***p <0.001 by paired Student t test. ns, not significant. (D) LAKs were serum and IL-2-starved for 4 hours followed by Gas6 stimulation for various time points. Cell lysates were immunoblotted with anti-PLCγ1, anti-p85, anti-LAT1, and β-actin antibodies. (E) LAKs from WT and Cbl-b KO mice were serum and IL-2 starved for 4 hours followed by Gas6 stimulation for various time points. Cell lysates were immunoblotted with anti-LAT1 and β-actin antibodies. The relative ratio of LAT1 to β-actin for each time point, normalized to the 0 timepoint for each genotype, is shown below the blots. One representative of three independent experiments is shown.

Article Snippet: Recombinant murine Gas6 was purchased from R&D systems (Minneapolis, MN).

Techniques: Inhibition, Enzyme-linked Immunosorbent Assay, Control

Journal: European journal of immunology

Article Title: TAM receptors attenuate murine NK cell responses via E3 ubiquitin ligase Cbl-b

doi: 10.1002/eji.201948204

Figure Lengend Snippet: (A) HA-tagged Tyro3 was incubated with truncated Cbl-b (TKB+RF), E1, E2, ubiquitin, and ATP in vitro for 1 hour and immunoblotted with anti-HA antibody. (B) Truncated Cbl-b (TKB+RF) was incubated with or without recombinant Tyro3, Axl, or Mer and with or without ATP in vitro and immunoblotted with anti-phosphotyrosine antibody. (C) LAKs were IL-2-starved for 18 hours and serum-starved for 4 hours followed by stimulation with Gas6 for various time points or (D) followed by stimulation with or without Gas6, BMS 777607 with Gas6, or anti-NK1.1 (PK136) with or without Gas6 for 60 minutes. Lysates were de-ubiquitinated with DUB USp2core, followed by immunoprecipitation with anti-phosphotyrosine and immunoblotting with anti-Cbl-b antibodies. (E) 10XHis-tagged Y→F Cbl-b point mutants were incubated with Tyro3 and ATP, followed by immunoblotting with anti-phosphotyrosine antibody. Y3F refers to Y106/133/363F triple mutant. (F) 10XHis-tagged Y→F Cbl-b point mutants were incubated with Tyro3, E1, E2, ubiquitin, and ATP for 1 hour and immunoblotted with anti-ubiquitin antibody. One representative of three independent experiments is shown.

Article Snippet: Recombinant murine Gas6 was purchased from R&D systems (Minneapolis, MN).

Techniques: Incubation, Ubiquitin Proteomics, In Vitro, Recombinant, Immunoprecipitation, Western Blot, Mutagenesis

Journal: European journal of immunology

Article Title: TAM receptors attenuate murine NK cell responses via E3 ubiquitin ligase Cbl-b

doi: 10.1002/eji.201948204

Figure Lengend Snippet: Gas6 binds and activates TAM receptors, which directly phosphorylates Cbl-b. Phosphorylated Cbl-b, in turn, ubiquitinates and targets LAT1 for degradation. NK1.1/NKG2D signaling is attenuated by decreased LAT1 protein, which is required for signal transduction downstream of NK cell activating receptors.

Article Snippet: Recombinant murine Gas6 was purchased from R&D systems (Minneapolis, MN).

Techniques: Transduction

Journal: European journal of immunology

Article Title: TAM receptors attenuate murine NK cell responses via E3 ubiquitin ligase Cbl-b

doi: 10.1002/eji.201948204

Figure Lengend Snippet: LAKs were serum/IL-2-starved for 2 hours, pre-treated with or without Gas6 for 2 hours, and left unstimulated (Unstim) or stimulated with PMA/Iono, anti-NK1.1, or anti-NKG2D for 5 hours and analyzed by flow cytometry using the strategy illustrated in Supporting Information (Figure S1A). (A) Representative flow cytometric plots of IFN-γ+ and CD107a+ LAK cells are shown. (B) The fraction of IFN-γ-expressing and (C) CD107a-expressing LAKs from 4 independent experiments are shown (n = 4 mice for anti-NK1.1 and n=5 mice for anti-NKG2D). (D) Splenoctyes from Poly I:C-treated mice were pre-treated with or without Gas6 for 2 hours and left unstimulated (Unstim) or stimulated with PMA/Iono or anti-NK1.1 for 5 hours and analyzed by flow cytometry using the strategy illustrated in Supporting Information (Figure S1B). Representative flow cytometric plots of IFN-γ+ and CD107a+ NK cells are shown. The fraction of (E) IFN-γ-expressing and (F) CD107a–expressing splenocytes of 4 independent experiments are shown (n =4–5 mice). *p<0.05 and **p<0.01 by paired Student t test, respectively; ns, not significant.

Article Snippet: Reagents, Flow cytometry, antibodies, and data analysis Recombinant murine Gas6 was purchased from R&D systems (Minneapolis, MN).

Techniques: Flow Cytometry, Expressing

Journal: European journal of immunology

Article Title: TAM receptors attenuate murine NK cell responses via E3 ubiquitin ligase Cbl-b

doi: 10.1002/eji.201948204

Figure Lengend Snippet: (A) LAKs were treated with media (0.05% DMSO) or BMS 777607 (100 nM) for 2 hours in IL-2/serum-free conditions, followed by treatment with or without Gas6 for another 2 hours prior to stimulation with anti-NK1.1 or NKG2D for 5 hours. Data is shown as mean % inhibition {(Untreated - Gas6-treated)/Untreated]*100} ± SEM of 4 independent experiments (n = 4–5 mice for anti-NK1.1 and n=5–6 mice for anti-NKG2D). P values were determined by paired Student t test. (B) WT and Cbl-b KO LAKs were serum/IL-2-starved for 2 hours, followed by Gas6 treatment for 2 hours, and stimulated with anti-NK1.1 or (C) anti-NKG2D antibodies for 24 hours. IFNγ content in the supernatants was measured by ELISA. Data are represented as % of control + SEM of n=4 mice for anti-NK1.1 and n=3 mice for anti-NKG2D. *p< 0.05 and ***p <0.001 by paired Student t test. ns, not significant. (D) LAKs were serum and IL-2-starved for 4 hours followed by Gas6 stimulation for various time points. Cell lysates were immunoblotted with anti-PLCγ1, anti-p85, anti-LAT1, and β-actin antibodies. (E) LAKs from WT and Cbl-b KO mice were serum and IL-2 starved for 4 hours followed by Gas6 stimulation for various time points. Cell lysates were immunoblotted with anti-LAT1 and β-actin antibodies. The relative ratio of LAT1 to β-actin for each time point, normalized to the 0 timepoint for each genotype, is shown below the blots. One representative of three independent experiments is shown.

Article Snippet: Reagents, Flow cytometry, antibodies, and data analysis Recombinant murine Gas6 was purchased from R&D systems (Minneapolis, MN).

Techniques: Inhibition, Enzyme-linked Immunosorbent Assay, Control

Journal: European journal of immunology

Article Title: TAM receptors attenuate murine NK cell responses via E3 ubiquitin ligase Cbl-b

doi: 10.1002/eji.201948204

Figure Lengend Snippet: (A) HA-tagged Tyro3 was incubated with truncated Cbl-b (TKB+RF), E1, E2, ubiquitin, and ATP in vitro for 1 hour and immunoblotted with anti-HA antibody. (B) Truncated Cbl-b (TKB+RF) was incubated with or without recombinant Tyro3, Axl, or Mer and with or without ATP in vitro and immunoblotted with anti-phosphotyrosine antibody. (C) LAKs were IL-2-starved for 18 hours and serum-starved for 4 hours followed by stimulation with Gas6 for various time points or (D) followed by stimulation with or without Gas6, BMS 777607 with Gas6, or anti-NK1.1 (PK136) with or without Gas6 for 60 minutes. Lysates were de-ubiquitinated with DUB USp2core, followed by immunoprecipitation with anti-phosphotyrosine and immunoblotting with anti-Cbl-b antibodies. (E) 10XHis-tagged Y→F Cbl-b point mutants were incubated with Tyro3 and ATP, followed by immunoblotting with anti-phosphotyrosine antibody. Y3F refers to Y106/133/363F triple mutant. (F) 10XHis-tagged Y→F Cbl-b point mutants were incubated with Tyro3, E1, E2, ubiquitin, and ATP for 1 hour and immunoblotted with anti-ubiquitin antibody. One representative of three independent experiments is shown.

Article Snippet: Reagents, Flow cytometry, antibodies, and data analysis Recombinant murine Gas6 was purchased from R&D systems (Minneapolis, MN).

Techniques: Incubation, Ubiquitin Proteomics, In Vitro, Recombinant, Immunoprecipitation, Western Blot, Mutagenesis

Journal: European journal of immunology

Article Title: TAM receptors attenuate murine NK cell responses via E3 ubiquitin ligase Cbl-b

doi: 10.1002/eji.201948204

Figure Lengend Snippet: Gas6 binds and activates TAM receptors, which directly phosphorylates Cbl-b. Phosphorylated Cbl-b, in turn, ubiquitinates and targets LAT1 for degradation. NK1.1/NKG2D signaling is attenuated by decreased LAT1 protein, which is required for signal transduction downstream of NK cell activating receptors.

Article Snippet: Reagents, Flow cytometry, antibodies, and data analysis Recombinant murine Gas6 was purchased from R&D systems (Minneapolis, MN).

Techniques: Transduction

Journal: Theranostics

Article Title: Regulatory T-cells regulate neonatal heart regeneration by potentiating cardiomyocyte proliferation in a paracrine manner

doi: 10.7150/thno.32734

Figure Lengend Snippet: The most significantly upregulated genes expressed by heart Treg during neonatal heart regeneration. Foxp3 + Treg are purified from the spleen or heart at day 7 post CI to P3 ICR mice. C1: upregulated genes in splenic naïve Treg; C2: upregulated genes in Treg following activation by neoantigens released during cryoinfarction in the heart.

Article Snippet: After that, they were cocultured with in vitro stimulated Treg in a ratio of cardiomyocytes: Treg as 3:1, Treg supernatant-containing dark medium (1:1) or 50 ng/ml murine CCL24 (Biolegend, 585102), 100 ng/ml murine GAS6 (RnD systems, 8310-GS-050), 1 ug/ml murine GRN (Lifespan biosciences, LS-G3786-10) or 100 ng/ml murine amphiregulin (RnD systems, 989-AR-100) at 37°C for 1 day before analysis.

Techniques: Purification, Activation Assay, Immunopeptidomics

Journal: Theranostics

Article Title: Regulatory T-cells regulate neonatal heart regeneration by potentiating cardiomyocyte proliferation in a paracrine manner

doi: 10.7150/thno.32734

Figure Lengend Snippet: Treg directly promote proliferation of mouse neonatal cardiomyocytes in a paracrine manner. Immunocytochemistry for cTnT + (red) and Ki67 + (green), pH3 + (green) or Aurora B + (green) cells at day 1 after coculture of (A) CD3 + CD4 + hCD2 + Treg, Treg supernatant (SN), or (G) the combination of CCL24, GAS6 and AREG (Pool 3) with mouse neonatal cardiomyocytes of P1 ICR hearts, scale bars: 50 um. Quantification of (B) the absolute number of total cTnT + cardiomyocytes after cocultured for 3 days; or (C) %Ki67 + cTnT + , (D) %pH3 + cTnT + or (E) %Aurora B + cTnT + proliferating cardiomyocytes among total cTnT + cardiomyocytes based on (A). Quantification of proliferating cardiomyocytes after cultured with (F) the respective paracrine factors or (H-J) Pool 3 for 1 day. Data are presented as mean±S.D., n = 3 independent experiments, *P<0.05, **P<0.01.

Article Snippet: After that, they were cocultured with in vitro stimulated Treg in a ratio of cardiomyocytes: Treg as 3:1, Treg supernatant-containing dark medium (1:1) or 50 ng/ml murine CCL24 (Biolegend, 585102), 100 ng/ml murine GAS6 (RnD systems, 8310-GS-050), 1 ug/ml murine GRN (Lifespan biosciences, LS-G3786-10) or 100 ng/ml murine amphiregulin (RnD systems, 989-AR-100) at 37°C for 1 day before analysis.

Techniques: Immunocytochemistry, Cell Culture

Journal: Nature

Article Title: The E3 Ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells

doi: 10.1038/nature12998

Figure Lengend Snippet: a, In vitro Cbl-b-dependent ubiquitylation of Tyro3, Axl, and Mer (anti-Ub). Control, no TAM receptors. Loading controls are shown. b, IFN-γ+ Cbl-b+/+ and Cbl-b-/- NK cells (%) stimulated with anti-NKG2D Abs in the presence of soluble Gas6. *P<0.05 (One-way ANOVA, Dunnett’s post hoc test, n=6/5). c, TAM receptors surface expression in NK cells after stimulation with Gas6. *P<0.05 (two-way ANOVA, Bonferroni’s post hoc test, n=10-13). d, Chemical structure of the TAM receptor kinase inhibitor LDC1267. e, IC50 values for the indicated protein kinases as determined by tracer assays. f, Remaining activity (compared to DMSO control) in 456 kinases treated with 1µM LDC1267 g, IFN-γ+ Cbl-b+/+ and Cbl-b-/- NK cells (%) pre-treated with vehicle or LDC1267 and then stimulated with anti-NKG2D Abs and Gas6. *P<0.05, n.s., not significant (Student’s t-test, n=11/8.). h, In vivo NK cytotoxicity towards RMA-Rae1 cells in mice treated with vehicle or LDC1267. *P<0.05, **P<0.01 (One-way ANOVA, Tukey’s post hoc test, n=16/14/9/10). i, Tumor-to-lung areas in B16F10 tumor-bearing B6 mice untreated or adoptively transplanted with NK cells ex vivo treated with vehicle or LDC1267. *P<0.05 and **P<0.01 (One-way ANOVA, Tukey’s post hoc test, n=16/16/16/10/10). Data in b,c,g-i are mean ± s.e.m.

Article Snippet: For Gas6 and Cbl-b co-immunoprecipitations, HeLa cells were serum-starved overnight and stimulated at 37°C with 450ng/ml recombinant His-tagged murine Gas6 (R&D System) for different time periods, and then lysed as described above.

Techniques: In Vitro, Expressing, Activity Assay, In Vivo, Ex Vivo